Form 4 for BSX Boston Scientific
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-25 · accession 0001225208-24-010179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-25 | 2024-11-25 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $21.40 | +4,186 | 15.0K | +39% | +$89.6K |
| D | 2024-11-25 | 2024-11-25 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $89.27 | -14.0K | 978 | -93% | -$1.25M |
| DM | 2024-11-25 | 2024-11-25 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -4,186 | 4,036 | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-25 | M | A | 3,177 | $22.71 | 13,979 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-25 | S | D | 14,010 | $89.27 | 978 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $88.76 to $89.74 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-11-25 | M | A | 1,009 | $17.26 | 14,988 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-11-25 | M | D | 3,177 | $0.00 | 12,706 | D | $22.71 · — to 2026-06-01 | 3,177 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-11-25 | M | D | 1,009 | $0.00 | 4,036 | D | $17.26 · — to 2026-02-22 | 1,009 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |